Joy Liu

CIK: 0001847529

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VRTX

VERTEX PHARMACEUTICALS INC / MA

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

VRTX
VERTEX PHARMACEUTICALS INC / MA
Jul 1, 2026
Sale(S)
Direct
828 shares at avg. $502.71$416K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jun 1, 2026
Sale(S)
Direct
828 shares at avg. $439.91$364K
VRTX
VERTEX PHARMACEUTICALS INC / MA
May 1, 2026
Sale(S)
Direct
1.1K shares at avg. $425.02$469K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Apr 1, 2026
Sale(S)
Direct
978 shares at avg. $449.17$439K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Mar 2, 2026
Sale(S)
Direct
892 shares at avg. $495.96$442K

		Type	Shares	Price		Ownership
Jul 1, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	828	$502.71	$416,244	Direct
Jun 1, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	828	$439.91	$364,245	Direct
May 1, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	1,104	$425.02	$469,222	Direct
Apr 1, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	978	$449.17	$439,288	Direct
Mar 2, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	892	$495.96	$442,396	Direct

1-5 of 5 transactions

About Liu Joy

Liu Joy (SEC CIK 0001847529) files insider reports with the SEC as EVP and Chief Legal Officer of VERTEX PHARMACEUTICALS INC / MA (VRTX).

Signal8 holds 6 ownership filings by Liu Joy (1 Form 3, 5 Form 4), filed between Mar 3, 2026 and Jul 6, 2026. Those filings report 5 transactions, from Mar 2, 2026 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Liu Joy's filings is in BOSTON, MA.

Recent filings by Liu Joy

Jul 1, 2026: Open-market sale of VRTX shares (Form 4, code S).
Jun 1, 2026: Open-market sale of VRTX shares (Form 4, code S).
May 1, 2026: Open-market sale of VRTX shares (Form 4, code S).
Apr 1, 2026: Open-market sale of VRTX shares (Form 4, code S).
Mar 2, 2026: Open-market sale of VRTX shares (Form 4, code S).

Other insiders filing for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Brennan Daniel J., Director
SACHS BRUCE I, Director
Garber Alan M, Director
van Grunsven Jasper, EVP, CP and NPPO
Ambrose Kristen, SVP & Chief Accounting Officer
Tatsis Ourania, EVP, Chief Reg. & Quality Off.

How to read Form 4 transaction codes